230 related articles for article (PubMed ID: 16103450)
1. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer.
Bertone-Johnson ER; Chen WY; Holick MF; Hollis BW; Colditz GA; Willett WC; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):1991-7. PubMed ID: 16103450
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of vitamin D metabolites and breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.
Freedman DM; Chang SC; Falk RT; Purdue MP; Huang WY; McCarty CA; Hollis BW; Graubard BI; Berg CD; Ziegler RG
Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):889-94. PubMed ID: 18381472
[TBL] [Abstract][Full Text] [Related]
3. Plasma 25-Hydroxyvitamin D and Risk of Breast Cancer in Women Followed over 20 Years.
Eliassen AH; Warner ET; Rosner B; Collins LC; Beck AH; Quintana LM; Tamimi RM; Hankinson SE
Cancer Res; 2016 Sep; 76(18):5423-30. PubMed ID: 27530324
[TBL] [Abstract][Full Text] [Related]
4. Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer--results of a large case-control study.
Abbas S; Linseisen J; Slanger T; Kropp S; Mutschelknauss EJ; Flesch-Janys D; Chang-Claude J
Carcinogenesis; 2008 Jan; 29(1):93-9. PubMed ID: 17974532
[TBL] [Abstract][Full Text] [Related]
5. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of incident ovarian cancer.
Tworoger SS; Lee IM; Buring JE; Rosner B; Hollis BW; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):783-8. PubMed ID: 17416771
[TBL] [Abstract][Full Text] [Related]
6. Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and adenomatous polyps of the distal colorectum.
Platz EA; Hankinson SE; Hollis BW; Colditz GA; Hunter DJ; Speizer FE; Giovannucci E
Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1059-65. PubMed ID: 11045788
[TBL] [Abstract][Full Text] [Related]
7. Mammographic density, plasma vitamin D levels and risk of breast cancer in postmenopausal women.
Green AK; Hankinson SE; Bertone-Johnson ER; Tamimi RM
Int J Cancer; 2010 Aug; 127(3):667-74. PubMed ID: 19960434
[TBL] [Abstract][Full Text] [Related]
8. Plasma vitamin D metabolites and risk of colorectal cancer in women.
Feskanich D; Ma J; Fuchs CS; Kirkner GJ; Hankinson SE; Hollis BW; Giovannucci EL
Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1502-8. PubMed ID: 15342452
[TBL] [Abstract][Full Text] [Related]
9. Circulating vitamin D metabolites in relation to subsequent development of prostate cancer.
Gann PH; Ma J; Hennekens CH; Hollis BW; Haddad JG; Stampfer MJ
Cancer Epidemiol Biomarkers Prev; 1996 Feb; 5(2):121-6. PubMed ID: 8850273
[TBL] [Abstract][Full Text] [Related]
10. Reduced prediagnostic 25-hydroxyvitamin D levels in women with breast cancer: a nested case-control study.
Rejnmark L; Tietze A; Vestergaard P; Buhl L; Lehbrink M; Heickendorff L; Mosekilde L
Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2655-60. PubMed ID: 19789365
[TBL] [Abstract][Full Text] [Related]
11. Premenopausal plasma 25-hydroxyvitamin D, mammographic density, and risk of breast cancer.
Bertrand KA; Rosner B; Eliassen AH; Hankinson SE; Rexrode KM; Willett W; Tamimi RM
Breast Cancer Res Treat; 2015 Jan; 149(2):479-87. PubMed ID: 25543181
[TBL] [Abstract][Full Text] [Related]
12. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.
Li H; Stampfer MJ; Hollis JB; Mucci LA; Gaziano JM; Hunter D; Giovannucci EL; Ma J
PLoS Med; 2007 Mar; 4(3):e103. PubMed ID: 17388667
[TBL] [Abstract][Full Text] [Related]
13. Circulating levels of 25-hydroxyvitamin D and risk of breast cancer: a nested case-control study.
Scarmo S; Afanasyeva Y; Lenner P; Koenig KL; Horst RL; Clendenen TV; Arslan AA; Chen Y; Hallmans G; Lundin E; Rinaldi S; Toniolo P; Shore RE; Zeleniuch-Jacquotte A
Breast Cancer Res; 2013 Feb; 15(1):R15. PubMed ID: 23442740
[TBL] [Abstract][Full Text] [Related]
14. Serum 25-hydroxyvitamin D and risk of breast cancer: results of a large population-based case-control study in Mexican women.
Fedirko V; Torres-Mejía G; Ortega-Olvera C; Biessy C; Angeles-Llerenas A; Lazcano-Ponce E; Saldaña-Quiroz VA; Romieu I
Cancer Causes Control; 2012 Jul; 23(7):1149-62. PubMed ID: 22622862
[TBL] [Abstract][Full Text] [Related]
15. Plasma 25-hydroxyvitamin D and premenopausal breast cancer risk in a German case-control study.
Abbas S; Chang-Claude J; Linseisen J
Int J Cancer; 2009 Jan; 124(1):250-5. PubMed ID: 18839430
[TBL] [Abstract][Full Text] [Related]
16. Plasma 25-hydroxyvitamin D and risk of breast cancer in the Nurses' Health Study II.
Eliassen AH; Spiegelman D; Hollis BW; Horst RL; Willett WC; Hankinson SE
Breast Cancer Res; 2011 May; 13(3):R50. PubMed ID: 21569367
[TBL] [Abstract][Full Text] [Related]
17. The Gc2 allele of the vitamin D binding protein is associated with a decreased postmenopausal breast cancer risk, independent of the vitamin D status.
Abbas S; Linseisen J; Slanger T; Kropp S; Mutschelknauss EJ; Flesch-Janys D; Chang-Claude J
Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1339-43. PubMed ID: 18559548
[TBL] [Abstract][Full Text] [Related]
18. Calcium and phosphorus regulatory hormones and risk of incident symptomatic kidney stones.
Taylor EN; Hoofnagle AN; Curhan GC
Clin J Am Soc Nephrol; 2015 Apr; 10(4):667-75. PubMed ID: 25623233
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D Status and Risk of Breast Cancer in Iranian Women: A Case-Control Study.
Jamshidinaeini Y; Akbari ME; Abdollahi M; Ajami M; Davoodi SH
J Am Coll Nutr; 2016; 35(7):639-646. PubMed ID: 27331363
[TBL] [Abstract][Full Text] [Related]
20. A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer.
Wu K; Feskanich D; Fuchs CS; Willett WC; Hollis BW; Giovannucci EL
J Natl Cancer Inst; 2007 Jul; 99(14):1120-9. PubMed ID: 17623801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]